All In Biotech

Drug Trial Radar · NCT04750902

A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

A Phase 2 Randomized, Double-blind, Active-controlled Multi-center Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices With 1.5%, 4.0% and 8.0% Arginine Each in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

Last checked: Nov 20, 2026Latest source record: Jul 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 2,025 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,025

Actual

Start

Jan 21, 2021

Primary completion

Feb 28, 2024

Study completion Feb 28, 2024

Sponsor

Lead sponsor
Colgate PalmoliveIndustry
Sponsor type
Industry
First posted
Feb 11, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 10 years, up to 14 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to assess the safety and to evaluate the anti-caries efficacy of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice in 10-14 year-old children over a one year period.

Conditions

  • Dental Caries

Interventions

  • 0.24% Sodium Fluoride DentifriceDrug

    Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study

  • 1.5% Arginine DentifriceDrug

    Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study

  • 4.0% Arginine DentifriceDrug

    Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study

  • 8.0% Arginine DentifriceDrug

    Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incremental Subject-wise Decayed Missing or Filled Surfaces (DMFS) Score Between the Baseline and the Month 12 VisitsTime frame: Between the Baseline and the Month 12 visits

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • Loma Linda University School of Dentistry

    Loma Linda, California

  • University of Florida College of Dentistry

    Gainesville, Florida

  • Indiana University School of Dentistry

    Indianapolis, Indiana

  • Tufts University School of Dental Medicine

    Boston, Massachusetts

  • The Forsyth Institute

    Boston, Massachusetts

  • University at Buffalo School of Dental Medicine

    Buffalo, New York

  • University of Pennsylvania School of Dental Medicine

    Philadelphia, Pennsylvania

  • UT Health San Antonio School of Dentistry

    San Antonio, Texas

  • University of Puerto Rico School of Dental Medicine

    San Juan, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.